Haemopoietic growth factors and childhood cancer

This publication has 20 references indexed in Scilit:

• Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias
  British Journal of Haematology, 1994
• The use of haemopoietic growth factors in blood disorders.
  Archives of Disease in Childhood, 1994
• Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation
  Blood Reviews, 1994
• Thrombopoietin — at last
  Nature, 1994
• Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
  The Lancet, 1994
• Indications and guidelines for the use of hematopoietic growth factors
  Transfusion, 1993
• Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow Transplantation
  New England Journal of Medicine, 1993
• Use of GM-CSF in children after high-dose chemotherapy
  Medical and Pediatric Oncology, 1992
• Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary report
  The American Journal of Medicine, 1989
• Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes
  New England Journal of Medicine, 1987